{"id":20499,"date":"2023-09-26T14:17:01","date_gmt":"2023-09-26T12:17:01","guid":{"rendered":"https:\/\/ichp.lukasiewicz.gov.pl\/offer-from-the-pharmaceutical-products-department\/"},"modified":"2024-08-12T13:46:06","modified_gmt":"2024-08-12T11:46:06","slug":"offer-from-the-pharmaceutical-products-department","status":"publish","type":"page","link":"https:\/\/ichp.lukasiewicz.gov.pl\/en\/offer-from-the-pharmaceutical-products-department\/","title":{"rendered":"Offer from the Pharmaceutical Products Department"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

OFFER<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Offer from the Pharmaceutical Products Department<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The Pharmaceutical Products Department is responsible for the highest quality of pharmaceutical manufacturing within the Institute. As an Active Pharmaceutical Ingredient (API) manufacturer,<\/strong> we distribute our products not only in Poland and the European market, but also globally, including to the demanding Japanese market. <\/p>\n

We are also the responsible entity and manufacturer of Biodribin\u00ae<\/strong> (cladribine) 1mg\/ml – solution for infusion. Our product has been present on the Polish market for years and is on the reimbursement list. <\/p>\n

We not only focus on commercial production, but also engage in development projects as a Contract Drug Manufacturer (CDMO) in the area of Active Pharmaceutical Substance (API)<\/strong>. Our competence in scaling up manufacturing in the GMP<\/strong> regime, validation of the manufacturing process and preparation of registration dossiers provide a solid foundation for innovative projects. <\/p>\n

We have two GMP-standard<\/strong> production departments located in Warsaw – one ensuring the production of gram quantities up to 1 kg, the other working on a semi-technical scale, allowing the production of batches of up to 100kg.<\/p>\n

In research and development projects, as well as in day-to-day production, we can move seamlessly from small-scale production to large – tens of kilogram quantities. Our production meets the highest GMP<\/strong> standards, confirming quality assurance at every stage. <\/p>\n

In terms of pharmaceutical services, we offer:<\/p>\n

\u2192<\/span> Development of an API synthesis path<\/strong><\/p>\n

\u2192<\/span> Manufacturing the substance on a laboratory scale<\/strong><\/p>\n

\u2192<\/span> Development of production technology<\/strong><\/p>\n

\u2192<\/span> Development of analytics<\/strong><\/p>\n

\u2192<\/span> Validation of analytical methods and manufacturing process<\/strong><\/p>\n

\u2192<\/span> Increase in production scale (from a few g to hundreds of kg)<\/strong><\/p>\n

\u2192<\/span> Preparation of registration documentation<\/strong><\/p>\n

\u2192<\/span> Production of active substances \/ technology transfer<\/strong><\/p>\n

\u2192<\/span> Sale of API<\/strong><\/p>\n

Experience, innovation and advanced infrastructure all make Lukasiewicz – IChP the first-choice partner for customers seeking not only a manufacturer, but also a partner in the dynamic pharmaceutical world.<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

List of substances offered by \u0141ukasiewicz – Industrial Chemistry Institute<\/h3>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\tAlfacalcidol API (certyfikat CEP)<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
\n\n\n\n
Numer CAS<\/strong><\/td>\nPole dzia\u0142ania<\/strong><\/td>\nDost\u0119pne certyfikaty<\/strong><\/td>\n<\/tr>\n
41294-56-8<\/td>\nregulator metabolizmu wapnia, analog witaminy D<\/td>\nCEP, GMP, ASMF<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\tAnastrozole API<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
\n\n\n\n
Numer CAS<\/strong><\/td>\nPole dzia\u0142ania<\/strong><\/td>\nDost\u0119pne certyfikaty<\/strong><\/td>\n<\/tr>\n
120511-73-1<\/td>\nprzeciwnowotworowy, niesteroidowy inhibitor aromatazy<\/td>\nGMP, ASMF<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\tBrinzolamide API<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
\n\n\n\n
Numer CAS<\/strong><\/td>\nPole dzia\u0142ania<\/strong><\/td>\nDost\u0119pne certyfikaty<\/strong><\/td>\n<\/tr>\n
138890-62-7<\/td>\njaskra, inhibitor anhydrazy w\u0119glanowe<\/td>\nASMF<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\tCalcifediol API (certyfikat CEP)<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
\n\n\n\n
Numer CAS<\/strong><\/td>\nPole dzia\u0142ania<\/strong><\/td>\nDost\u0119pne certyfikaty<\/strong><\/td>\n<\/tr>\n
19356-17-3<\/td>\nregulator metabolizmu wapnia, analog witaminy D<\/td>\nCEP, GMP, ASMF<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\tCarvedilol API<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
\n\n\n\n
Numer CAS<\/strong><\/td>\nPole dzia\u0142ania<\/strong><\/td>\nDost\u0119pne certyfikaty<\/strong><\/td>\n<\/tr>\n
72956-09-3<\/td>\nleki sercowo-naczyniowe, beta-adrenolityki<\/td>\nGMP, ASMF<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\tCilostazol API<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
\n\n\n\n
Numer CAS<\/strong><\/td>\nPole dzia\u0142ania<\/strong><\/td>\nDost\u0119pne certyfikaty<\/strong><\/td>\n<\/tr>\n
73963-72-1<\/td>\ninhibitor fosfodiesterazy PDE3 – hamuje agregacj\u0119 p\u0142ytek krwi oraz rozszerza naczynia krwiono\u015bne<\/td>\nASMF<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\tCladribine API<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
\n\n\n\n
Numer CAS<\/strong><\/td>\nPole dzia\u0142ania<\/strong><\/td>\nDost\u0119pne certyfikaty<\/strong><\/td>\n<\/tr>\n
4291-63-8<\/td>\nAntagonista purynowy, syntetyczna pochodna deoksyadenozyny (dA)<\/td>\nGMP, ASMF<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t(+)-Clopidogrel Hydrogen sulfate, polymorphic form I API<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
\n\n\n\n
Numer CAS<\/strong><\/td>\nPole dzia\u0142ania<\/strong><\/td>\nDost\u0119pne certyfikaty<\/strong><\/td>\n<\/tr>\n
120202-66-6<\/td>\ninhibitor agregacji p\u0142ytek krwi, pochodna tienopirydyny<\/td>\nGMP, ASMF<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\tGenistein synthetic API<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
\n\n\n\n
Numer CAS<\/strong><\/td>\nPole dzia\u0142ania<\/strong><\/td>\nDost\u0119pne certyfikaty<\/strong><\/td>\n<\/tr>\n
446-72-0<\/td>\nFitoestrogen z grupy izoflawon\u00f3w<\/td>\nASMF<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\tImatinib mesylate polymorphic form \u03b1 API<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
\n\n\n\n
Numer CAS<\/strong><\/td>\nPole dzia\u0142ania<\/strong><\/td>\nDost\u0119pne certyfikaty<\/strong><\/td>\n<\/tr>\n
220127-57-1<\/td>\ninhibitor\u00f3w kinaz bia\u0142kowych (hamuje receptory kinazy tyrozynowej)<\/td>\nGMP, ASMF<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\tLatanoprost API<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
\n\n\n\n
Numer CAS<\/strong><\/td>\nPole dzia\u0142ania<\/strong><\/td>\nDost\u0119pne certyfikaty<\/strong><\/td>\n<\/tr>\n
130209-82-4<\/td>\njaskra z otwartym k\u0105tem przes\u0105czania, nadci\u015bnienie \u015br\u00f3dga\u0142kowe, pochodna prostaglandyny<\/td>\nGMP, ASMF<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\tNitrendipine API<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
\n\n\n\n
Numer CAS<\/strong><\/td>\nPole dzia\u0142ania<\/strong><\/td>\nDost\u0119pne certyfikaty<\/strong><\/td>\n<\/tr>\n
39562-70-4<\/td>\nantagonista wapnia (bloker kana\u0142u wapniowego)<\/td>\nGMP, ASMF<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\tOlanzapine polymorphic form I API<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
\n\n\n\n
Numer CAS<\/strong><\/td>\nPole dzia\u0142ania<\/strong><\/td>\nDost\u0119pne certyfikaty<\/strong><\/td>\n<\/tr>\n
132539-06-1<\/td>\nlek antypsychotyczny, antagonista serotoniny\/dopaminy<\/td>\nGMP, ASMF<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\tParicalcitol API<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
\n\n\n\n
Numer CAS<\/strong><\/td>\nPole dzia\u0142ania<\/strong><\/td>\nDost\u0119pne certyfikaty<\/strong><\/td>\n<\/tr>\n
131918-61-1<\/td>\ninhibitor wydzielania hormonu przytarczyc, analog witaminy D<\/td>\nGMP, ASMF<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\tPramipexole dihydrochloride, monohydrate API<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
\n\n\n\n
Numer CAS<\/strong><\/td>\nPole dzia\u0142ania<\/strong><\/td>\nDost\u0119pne certyfikaty<\/strong><\/td>\n<\/tr>\n
104632-26-0<\/td>\nwybi\u00f3rczy agonista receptor\u00f3w dopaminowych, choroba Parkinsona<\/td>\nASMF<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\tTacalcitol API (certyfikat CEP)<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
\n\n\n\n
Numer CAS<\/strong><\/td>\nPole dzia\u0142ania<\/strong><\/td>\nDost\u0119pne certyfikaty<\/strong><\/td>\n<\/tr>\n
57333-96-7<\/td>\nwybi\u00f3rczy agonista receptor\u00f3w dopaminowych, choroba Parkinsona<\/td>\nCEP, GMP, ASMF<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Technologies ready for implementation<\/h3>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\tCalcitriol API (certyfikat CEP)<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
\n\n\n\n
Numer CAS<\/strong><\/td>\nPole dzia\u0142ania<\/strong><\/td>\nDost\u0119pne certyfikaty<\/strong><\/td>\n<\/tr>\n
32222-06-3<\/td>\nregulator metabolizmu wapnia, analog witaminy D<\/td>\nCEP, GMP, ASMF<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Medicinal product<\/h3>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\tBIODRIBIN<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
\n\n\n\n
Pole dzia\u0142ania<\/strong><\/td>\nDost\u0119pne certyfikaty<\/strong><\/td>\n<\/tr>\n
lek przeciwnowotworowy stosowany w chemioterapii nowotwor\u00f3w (bia\u0142aczka w\u0142ochatokom\u00f3rkowa, przewlek\u0142a bia\u0142aczka limfatyczna, ch\u0142oniaki nieziarniczne)<\/td>\nGMP<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

ASMF<\/strong> – Active Substance Master File<\/p>\n

GMP<\/strong> \u2013 Certyfikat GMP wydany przez G\u0142\u00f3wny Inspektorat Farmaceutyczny<\/p>\n

CEP<\/strong> – Certificate of Suitability issued by EDQM (European Directorate for the Quality in Medicines and Healthcare)<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
Download:<\/strong><\/h5>\n

List of substances<\/a><\/a><\/p>\n

List of analytical benchmarks<\/a><\/a><\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

For more details about analytical standards produced by \u0141ukasiewicz Research Network – Industrial Chemistry Institute contact anna.nikonowicz@ichp.lukasiewicz.gov.pl<\/a><\/strong><\/em><\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
Contact<\/strong><\/h6>\n
Anna Nikonowicz, PhD Sc.<\/h6>\n
phone +48 601 191 135<\/h6>\n
anna.nikonowicz@ichp.lukasiewicz.gov.pl<\/a><\/h6>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

\/*! elementor – v3.21.0 – 26-05-2024 *\/ .elementor-heading-title{padding:0;margin:0;line-height:1}.elementor-widget-heading .elementor-heading-title[class*=elementor-size-]>a{color:inherit;font-size:inherit;line-height:inherit}.elementor-widget-heading .elementor-heading-title.elementor-size-small{font-size:15px}.elementor-widget-heading .elementor-heading-title.elementor-size-medium{font-size:19px}.elementor-widget-heading .elementor-heading-title.elementor-size-large{font-size:29px}.elementor-widget-heading .elementor-heading-title.elementor-size-xl{font-size:39px}.elementor-widget-heading .elementor-heading-title.elementor-size-xxl{font-size:59px} OFFER Offer from the Pharmaceutical Products Department \/*! elementor – v3.21.0 – 26-05-2024 *\/ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=”.svg”]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} \/*! elementor – v3.21.0 – 26-05-2024 *\/ .elementor-widget-divider{–divider-border-style:none;–divider-border-width:1px;–divider-color:#0c0d0e;–divider-icon-size:20px;–divider-element-spacing:10px;–divider-pattern-height:24px;–divider-pattern-size:20px;–divider-pattern-url:none;–divider-pattern-repeat:repeat-x}.elementor-widget-divider .elementor-divider{display:flex}.elementor-widget-divider .elementor-divider__text{font-size:15px;line-height:1;max-width:95%}.elementor-widget-divider .elementor-divider__element{margin:0 var(–divider-element-spacing);flex-shrink:0}.elementor-widget-divider .elementor-icon{font-size:var(–divider-icon-size)}.elementor-widget-divider .elementor-divider-separator{display:flex;margin:0;direction:ltr}.elementor-widget-divider–view-line_icon .elementor-divider-separator,.elementor-widget-divider–view-line_text .elementor-divider-separator{align-items:center}.elementor-widget-divider–view-line_icon .elementor-divider-separator:after,.elementor-widget-divider–view-line_icon .elementor-divider-separator:before,.elementor-widget-divider–view-line_text .elementor-divider-separator:after,.elementor-widget-divider–view-line_text .elementor-divider-separator:before{display:block;content:””;border-block-end:0;flex-grow:1;border-block-start:var(–divider-border-width) var(–divider-border-style) var(–divider-color)}.elementor-widget-divider–element-align-left […]<\/p>\n","protected":false},"author":125,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","inline_featured_image":false,"footnotes":""},"class_list":["post-20499","page","type-page","status-publish","hentry"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-02-15 20:11:18","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"translation_priority","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/ichp.lukasiewicz.gov.pl\/en\/wp-json\/wp\/v2\/pages\/20499","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ichp.lukasiewicz.gov.pl\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ichp.lukasiewicz.gov.pl\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ichp.lukasiewicz.gov.pl\/en\/wp-json\/wp\/v2\/users\/125"}],"replies":[{"embeddable":true,"href":"https:\/\/ichp.lukasiewicz.gov.pl\/en\/wp-json\/wp\/v2\/comments?post=20499"}],"version-history":[{"count":4,"href":"https:\/\/ichp.lukasiewicz.gov.pl\/en\/wp-json\/wp\/v2\/pages\/20499\/revisions"}],"predecessor-version":[{"id":20509,"href":"https:\/\/ichp.lukasiewicz.gov.pl\/en\/wp-json\/wp\/v2\/pages\/20499\/revisions\/20509"}],"wp:attachment":[{"href":"https:\/\/ichp.lukasiewicz.gov.pl\/en\/wp-json\/wp\/v2\/media?parent=20499"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}